Atreca, Inc. Made Headway

Fri, Jan 12, 2024 at 07:37 PM
Atreca, Inc. Made Headway

Atreca, Inc. (BCEL:NASDAQ) jumped higher at $0.36, representing a gain of 52.6%. On Fri, Jan 12, 2024, BCEL:NASDAQ hit a New 2-Week High of $0.36. The stock got featured on our News Catalysts scanner on Tue, Dec 26, 2023 at 12:50 PM in the 'ACQUISITION' category. From Fri, Dec 29, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days

About Atreca, Inc. (BCEL:NASDAQ)

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.